@docrogmarc
Joined October 2022
  • Tweets11
  • Following66
  • Followers21
This multicenter study of 43 consecutive patients with severe AS reported the outcomes of #TAVR with a novel transfemoral, self-expanding #THV - the #JenaValve Trilogy jacc.org/doi/10.1016/j.jcin.… #JACCINT #vhdAS
13
52
6,382
DanGer Shock! The first temporary mechanical support device shown to reduce mortality in patients with cardiogenic shock but there is an increased risk of complications. @ShashankSinhaMD @ShelleyZieroth @JasonKatzMD @thiele_holger @DrDamluji @agtruesdell @Cardio_Girl
4
35
1
115
46,795
🔥out now —> here’s our new paper from the MyBiopsy-HF study — enjoy !👉🏻Etiologies and predictors of mortality in an all-comer population of patients with non-ischemic heart failure | Clinical Research in Cardiology link.springer.com/article/10…

Etiologies and predictors of mortality in an all-comer population of patients with non-ischemic...

Clinical Research in Cardiology - Despite progress in diagnosis and therapy of heart failure (HF), etiology and risk stratification remain elusive in many patients. The My Biopsy HF Study (German...

link.springer.com
4
14
1,144
The #ApolloEU #trial is now training and initiating trial centers in #Germany in December 2023. A new perspective for patients not suitable for heart surgery and #Mitralvalve TEER procedures. Initial US safety data very promising! More information [email protected]
4
19
1,864
Happy to discuss results about catheter-directed treatment #cdt from our presented socio-economic model with leaders in the field of #pulmonaryembolism and the current president of the #PERTconsortium #aha2023 @RosovskyRachel #timothymorris @StavrosKonstan7
2
15
889
Worldwide first commercial #EVOQUE case today at #HeartvalveCenter #Mainz ⁦@UnimedizinMainz⁩ closing the loop from interventional innovation to clinical reality a result of robust science a fantastic newly enhanced heart team. ⁦@PhilippLurz⁩ ⁦@vonBardelebenRS⁩
6
9
85
8,408
News in EHJ: Promises and challenges of targeting anti-CXCR3 autoantibodies in cardiovascular disease! academic.oup.com/eurheartj/a… #cardioprotective #therapy #autoantibodies #G-protein #receptors #cardiotwitter @escardio @ESC_journals
12
34
4,401
First implant worldwide of #Topaz transcatheter Tricuspid replacement in torrential TR in comb with pacemaker lead at Heart Valve Center in #Mainz and new in class 4D ICE to be shown at #EACTS in Vienna and #TCT in #SanFrancisco ⁦@vonBardelebenRS⁩ linkedin.com/posts/von-barde…

#topaz #tricuspid #pacemaker #mainz #eacts #vienna #tct #heartteam #mainz #inthecenterofyourheart...

Another device innovation with #Topaz first worldwide implant for torrential #tricuspid regurgitation in combination with #pacemaker leads treated this week in #Mainz to be presented at the European...

linkedin.com
1
3
25
2,575
Donnerstag, 11h, Saal 12! AG44 goes DGK FT23!
1
3
232
How come that noise exposure worsens outcomes post MI? Here‘s our new translational paper how environmental stress promotes vascular inflammation and deterioration of cardiac function @tmuenzel @OmarHahad @dzhk_germany academic.oup.com/cardiovascr…

Aircraft noise exposure induces pro-inflammatory vascular conditioning and amplifies vascular...

AbstractAims. Traffic noise may play an important role in the development and deterioration of ischaemic heart disease. Thus, we sought to determine the me

academic.oup.com
1
10
1
17
2,051
Our recent study demonstrated a considerable impact of COVID-19 on adverse outcomes of patients with #pulmonaryembolism in 2020, which should guide attention to this special population. bit.ly/3zz3OjZ @EuroRespSoc @escardio @DIVI_eV @UnimedizinMainz
4
15
1,018
Load more